Molecular Vaccines
From Prophylaxis to Therapy
Seiten
2020
|
1st ed. 2014
Springer International Publishing
978-3-319-01142-4 (ISBN)
Springer International Publishing
978-3-319-01142-4 (ISBN)
Part of a two-volume set, this title offers detailed insight into all aspects of molecular vaccine development and application. It illustrates the complete process of vaccine development from bench to preclinical and clinical studies and launch to the market.
The set of two volumes gives an detailed insight to all aspects of molecular vaccine development and application. Volume one provides a comprehensive overview to all aspects of global molecular vaccine research. It introduces concepts of vaccine immunology and molecular vaccine development for viral, bacterial, parasitic and fungal infections. Furthermore, the complex topic of cancer vaccines is discussed in detail. Volume two discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth.Molecular Vaccines from Prophylaxis to Therapy is of interest for researchers and clinicians engaged in molecular vaccine development and application.
The set of two volumes gives an detailed insight to all aspects of molecular vaccine development and application. Volume one provides a comprehensive overview to all aspects of global molecular vaccine research. It introduces concepts of vaccine immunology and molecular vaccine development for viral, bacterial, parasitic and fungal infections. Furthermore, the complex topic of cancer vaccines is discussed in detail. Volume two discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth.Molecular Vaccines from Prophylaxis to Therapy is of interest for researchers and clinicians engaged in molecular vaccine development and application.
Erscheint lt. Verlag | 1.1.2020 |
---|---|
Zusatzinfo | 750 p. 800 illus., 200 illus. in color. 2 volume-set. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
Medizin / Pharmazie ► Pharmazie | |
Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie | |
Schlagworte | cell vaccines • Delivery systems • Impfstoff • Impfstoff / Vakzine • Molecular Biology • molecular vaccines • prophylaxis and therapy • vaccine adjuvants • vaccines • vaccine tools |
ISBN-10 | 3-319-01142-1 / 3319011421 |
ISBN-13 | 978-3-319-01142-4 / 9783319011424 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
International Student Edition
Media-Kombination (2022)
WW Norton & Co
89,95 €